Ovarian Cancer
- Home
- Ovarian Cancer
Ovarian Cancer – Symptoms, Diagnosis & Advanced Treatment Options at RCERT
Ovarian cancer is one of the most serious and difficult-to-detect cancers affecting women, often diagnosed at a late stage due to subtle early symptoms. It originates in the ovaries — the female reproductive glands responsible for producing eggs and hormones such as estrogen and progesterone.
At RCERT (Regional Cell Research & Therapy Centre), we are committed to transforming how ovarian cancer is diagnosed and treated through personalized medicine, cell therapy, and regenerative immunotherapy. By integrating cutting-edge technology with expert clinical care, we offer new hope for women battling this disease.
🧬 What Is Ovarian Cancer?
Ovarian cancer develops when abnormal cells in the ovary begin to multiply uncontrollably and form a tumor. If not detected early, it can spread to other parts of the reproductive system and abdominal cavity.
There are several types of ovarian cancer:
Epithelial ovarian cancer (most common)
Germ cell tumors (rare; occurs in younger women)
Stromal tumors (involving hormone-producing cells)
Epithelial ovarian cancer accounts for about 90% of all cases and is typically diagnosed in women over 50.
⚠️ Early Signs and Symptoms
One of the biggest challenges in treating ovarian cancer is early detection. Symptoms are often vague and may mimic gastrointestinal or urinary issues.
Common early signs include:
Persistent bloating or abdominal swelling
Pelvic or lower abdominal pain
Frequent or urgent urination
Feeling full quickly when eating
Unexplained fatigue
Menstrual irregularities or postmenopausal bleeding
If these symptoms persist for more than a few weeks, medical evaluation is recommended.
🧪 Diagnosis of Ovarian Cancer
At RCERT, we use a combination of diagnostic tools for early detection and treatment planning:
Pelvic examination
Transvaginal ultrasound (TVUS)
CA-125 blood test – measures a tumor marker often elevated in ovarian cancer
CT or MRI scans – to evaluate the extent of the disease
Biopsy or surgical removal – to confirm cancer and determine type and stage
Genetic testing (e.g., BRCA1/2 mutations) may also be offered, especially for patients with a family history of cancer.
📊 Staging of Ovarian Cancer
Ovarian cancer is staged from Stage I (confined to ovaries) to Stage IV (spread to distant organs).
Stage I: Limited to one or both ovaries
Stage II: Spread to pelvic structures
Stage III: Spread to abdominal cavity or lymph nodes
Stage IV: Spread to distant organs like lungs or liver
Staging is critical to choosing the most appropriate treatment approach.
🧬 Advanced Treatment Options at RCERT
While traditional treatment for ovarian cancer often includes surgery and chemotherapy, RCERT takes a personalized, integrative approach that includes advanced cell-based therapies for better outcomes and immune recovery.
🔹 1. Surgery
Often the first step — involves removal of ovaries, fallopian tubes, uterus, and visible tumor tissue.
Aimed at cytoreduction (debulking) to improve the effectiveness of follow-up therapies.
🔹 2. Chemotherapy
Usually involves a combination of carboplatin and paclitaxel
Administered post-surgery or in advanced cases to shrink tumors
RCERT provides immune support therapy to help patients recover more quickly from chemotherapy-induced immune suppression.
🌿 RCERT’s Integrative Cell Therapy Approach
We go beyond conventional treatment by offering immune-based, cell-driven therapies to:
Strengthen the body’s natural cancer defense
Reduce recurrence
Support tissue repair and hormonal recovery
Our ovarian cancer care protocols may include:
🔬 DC-CIK Therapy
Dendritic Cell – Cytokine-Induced Killer Cell therapy combines immune education and targeted tumor cell destruction. DCs “teach” CIK cells to recognize ovarian tumor markers, increasing their effectiveness.
🔬 DC-CTL Therapy
A precision-targeted therapy where cytotoxic T lymphocytes (CTLs) are activated using tumor antigens presented by dendritic cells. This generates a highly specific immune attack against ovarian cancer cells.
🔬 NK Cell Therapy
Natural Killer (NK) Cells offer broad, non-MHC-restricted cytotoxicity — especially helpful in preventing cancer spread and recurrence.
🔬 Exosome and Secretome Therapy
Supports tissue recovery, reduces inflammation, and may enhance the immune response post-chemotherapy or surgery.
👩🔬 Research & Clinical Trials
RCERT is actively engaged in cell therapy clinical trials, including applications for:
Recurrent ovarian cancer
Platinum-resistant cancer cases
Immunotherapy combinations with DNA methylation screening
We also collaborate with UNIMAS Sarawak and Zhongrong Cell Technology Center (China) on ongoing ovarian cancer cell therapy studies.
❤️ Anti-Aging and Fertility Recovery Support
For younger women, ovarian cancer treatment can affect hormonal balance and fertility. RCERT offers:
MSC Stem Cell Therapy to support ovarian tissue repair
DNA Methylation Testing for biological age tracking
IV Nutritional Therapy and hormone support
Wellness consultation to help with physical and emotional recovery
👩 Who’s at Risk?
Risk factors for ovarian cancer include:
Age (most common after 50)
Family history of ovarian or breast cancer
BRCA1 or BRCA2 gene mutations
Endometriosis
Postmenopausal hormone therapy
Early menstruation or late menopause
However, many women with ovarian cancer have no clear risk factors, making awareness and regular screening essential.
✅ Why Choose RCERT?
✅ Personalized cancer treatment plans
✅ Integrative use of regenerative cell therapy
✅ GMP-certified lab facilities
✅ International research partnerships
✅ Patient-centered, minimally invasive options
✅ Focus on both recovery and long-term immunity
📞 Talk to Our Team Today
Ovarian cancer doesn’t have to be a silent killer. With early detection and the right treatment plan, recovery and long-term survival are possible.
At RCERT, we are dedicated to supporting you every step of the way — from diagnosis to recovery — with cutting-edge science and compassionate care.
Contact us now to schedule a consultation or request more information.